nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—CYP3A5—Sorafenib—thyroid cancer	0.222	0.44	CbGbCtD
Argatroban—CYP3A4—Vandetanib—thyroid cancer	0.144	0.285	CbGbCtD
Argatroban—CYP3A4—Sorafenib—thyroid cancer	0.0867	0.172	CbGbCtD
Argatroban—CYP3A4—Doxorubicin—thyroid cancer	0.0526	0.104	CbGbCtD
Argatroban—Haemoptysis—Vandetanib—thyroid cancer	0.016	0.0323	CcSEcCtD
Argatroban—Haematoma—Sorafenib—thyroid cancer	0.0127	0.0257	CcSEcCtD
Argatroban—Respiratory failure—Vandetanib—thyroid cancer	0.012	0.0244	CcSEcCtD
Argatroban—Pleural effusion—Sorafenib—thyroid cancer	0.0104	0.0211	CcSEcCtD
Argatroban—Sepsis—Vandetanib—thyroid cancer	0.0103	0.0208	CcSEcCtD
Argatroban—Myocardial ischaemia—Sorafenib—thyroid cancer	0.00992	0.0201	CcSEcCtD
Argatroban—Atrial fibrillation—Vandetanib—thyroid cancer	0.00906	0.0183	CcSEcCtD
Argatroban—Dermatitis bullous—Vandetanib—thyroid cancer	0.00898	0.0182	CcSEcCtD
Argatroban—Gastrooesophageal reflux disease—Sorafenib—thyroid cancer	0.00883	0.0179	CcSEcCtD
Argatroban—Cardiac failure—Vandetanib—thyroid cancer	0.0088	0.0178	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Vandetanib—thyroid cancer	0.00858	0.0174	CcSEcCtD
Argatroban—Cardiac arrest—Vandetanib—thyroid cancer	0.00816	0.0165	CcSEcCtD
Argatroban—Bullous eruption—Epirubicin—thyroid cancer	0.00746	0.0151	CcSEcCtD
Argatroban—Bullous eruption—Doxorubicin—thyroid cancer	0.0069	0.014	CcSEcCtD
Argatroban—Pneumonia—Vandetanib—thyroid cancer	0.00665	0.0135	CcSEcCtD
Argatroban—Urinary tract infection—Vandetanib—thyroid cancer	0.00643	0.013	CcSEcCtD
Argatroban—Haematuria—Vandetanib—thyroid cancer	0.00631	0.0128	CcSEcCtD
Argatroban—Renal failure acute—Sorafenib—thyroid cancer	0.00627	0.0127	CcSEcCtD
Argatroban—Kidney function abnormal—Epirubicin—thyroid cancer	0.0061	0.0123	CcSEcCtD
Argatroban—Bradycardia—Vandetanib—thyroid cancer	0.00605	0.0122	CcSEcCtD
Argatroban—Haemoglobin—Vandetanib—thyroid cancer	0.00597	0.0121	CcSEcCtD
Argatroban—Haemorrhage—Vandetanib—thyroid cancer	0.00594	0.012	CcSEcCtD
Argatroban—Cardiac failure—Sorafenib—thyroid cancer	0.00593	0.012	CcSEcCtD
Argatroban—Kidney function abnormal—Doxorubicin—thyroid cancer	0.00564	0.0114	CcSEcCtD
Argatroban—Angiopathy—Vandetanib—thyroid cancer	0.00539	0.0109	CcSEcCtD
Argatroban—Cough—Vandetanib—thyroid cancer	0.00451	0.00913	CcSEcCtD
Argatroban—Pneumonia—Sorafenib—thyroid cancer	0.00449	0.00908	CcSEcCtD
Argatroban—Chest pain—Vandetanib—thyroid cancer	0.0044	0.00891	CcSEcCtD
Argatroban—Acute coronary syndrome—Sorafenib—thyroid cancer	0.0044	0.0089	CcSEcCtD
Argatroban—Myocardial infarction—Sorafenib—thyroid cancer	0.00437	0.00885	CcSEcCtD
Argatroban—Haematemesis—Epirubicin—thyroid cancer	0.00424	0.00859	CcSEcCtD
Argatroban—Infection—Vandetanib—thyroid cancer	0.00419	0.00848	CcSEcCtD
Argatroban—Thrombosis—Epirubicin—thyroid cancer	0.00417	0.00843	CcSEcCtD
Argatroban—Haemoglobin—Sorafenib—thyroid cancer	0.00403	0.00815	CcSEcCtD
Argatroban—Haemorrhage—Sorafenib—thyroid cancer	0.00401	0.00811	CcSEcCtD
Argatroban—Haemoptysis—Epirubicin—thyroid cancer	0.00398	0.00806	CcSEcCtD
Argatroban—Haematemesis—Doxorubicin—thyroid cancer	0.00393	0.00794	CcSEcCtD
Argatroban—Thrombosis—Doxorubicin—thyroid cancer	0.00385	0.0078	CcSEcCtD
Argatroban—Pleural effusion—Epirubicin—thyroid cancer	0.00385	0.00779	CcSEcCtD
Argatroban—Dyspnoea—Vandetanib—thyroid cancer	0.00376	0.00761	CcSEcCtD
Argatroban—Dyspepsia—Vandetanib—thyroid cancer	0.00371	0.00751	CcSEcCtD
Argatroban—Haemoptysis—Doxorubicin—thyroid cancer	0.00369	0.00746	CcSEcCtD
Argatroban—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00364	0.00737	CcSEcCtD
Argatroban—Angiopathy—Sorafenib—thyroid cancer	0.00363	0.00735	CcSEcCtD
Argatroban—Constipation—Vandetanib—thyroid cancer	0.00361	0.0073	CcSEcCtD
Argatroban—Pain—Vandetanib—thyroid cancer	0.00361	0.0073	CcSEcCtD
Argatroban—Pleural effusion—Doxorubicin—thyroid cancer	0.00356	0.00721	CcSEcCtD
Argatroban—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00345	0.00698	CcSEcCtD
Argatroban—Vasodilation procedure—Epirubicin—thyroid cancer	0.00336	0.00679	CcSEcCtD
Argatroban—Vasodilation—Epirubicin—thyroid cancer	0.00336	0.00679	CcSEcCtD
Argatroban—Abdominal pain—Vandetanib—thyroid cancer	0.00334	0.00675	CcSEcCtD
Argatroban—Body temperature increased—Vandetanib—thyroid cancer	0.00334	0.00675	CcSEcCtD
Argatroban—Vasodilation—Doxorubicin—thyroid cancer	0.0031	0.00628	CcSEcCtD
Argatroban—Vasodilation procedure—Doxorubicin—thyroid cancer	0.0031	0.00628	CcSEcCtD
Argatroban—Cough—Sorafenib—thyroid cancer	0.00304	0.00616	CcSEcCtD
Argatroban—Ventricular tachycardia—Epirubicin—thyroid cancer	0.00295	0.00597	CcSEcCtD
Argatroban—Pulmonary embolism—Epirubicin—thyroid cancer	0.00295	0.00597	CcSEcCtD
Argatroban—Diarrhoea—Vandetanib—thyroid cancer	0.00289	0.00584	CcSEcCtD
Argatroban—Infection—Sorafenib—thyroid cancer	0.00283	0.00572	CcSEcCtD
Argatroban—Dizziness—Vandetanib—thyroid cancer	0.00279	0.00565	CcSEcCtD
Argatroban—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.00273	0.00552	CcSEcCtD
Argatroban—Pulmonary embolism—Doxorubicin—thyroid cancer	0.00273	0.00552	CcSEcCtD
Argatroban—Vomiting—Vandetanib—thyroid cancer	0.00268	0.00543	CcSEcCtD
Argatroban—Rash—Vandetanib—thyroid cancer	0.00266	0.00538	CcSEcCtD
Argatroban—Dermatitis—Vandetanib—thyroid cancer	0.00266	0.00538	CcSEcCtD
Argatroban—Headache—Vandetanib—thyroid cancer	0.00264	0.00535	CcSEcCtD
Argatroban—Pulmonary oedema—Epirubicin—thyroid cancer	0.00262	0.00531	CcSEcCtD
Argatroban—Sepsis—Epirubicin—thyroid cancer	0.00256	0.00518	CcSEcCtD
Argatroban—Dyspnoea—Sorafenib—thyroid cancer	0.00254	0.00513	CcSEcCtD
Argatroban—Nausea—Vandetanib—thyroid cancer	0.00251	0.00507	CcSEcCtD
Argatroban—Dyspepsia—Sorafenib—thyroid cancer	0.00251	0.00507	CcSEcCtD
Argatroban—Thrombophlebitis—Epirubicin—thyroid cancer	0.00247	0.005	CcSEcCtD
Argatroban—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00246	0.00497	CcSEcCtD
Argatroban—Pain—Sorafenib—thyroid cancer	0.00243	0.00492	CcSEcCtD
Argatroban—Constipation—Sorafenib—thyroid cancer	0.00243	0.00492	CcSEcCtD
Argatroban—Pulmonary oedema—Doxorubicin—thyroid cancer	0.00243	0.00491	CcSEcCtD
Argatroban—Sepsis—Doxorubicin—thyroid cancer	0.00237	0.00479	CcSEcCtD
Argatroban—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00233	0.00471	CcSEcCtD
Argatroban—Renal failure acute—Epirubicin—thyroid cancer	0.00232	0.00469	CcSEcCtD
Argatroban—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00229	0.00463	CcSEcCtD
Argatroban—Abdominal pain—Sorafenib—thyroid cancer	0.00225	0.00455	CcSEcCtD
Argatroban—Body temperature increased—Sorafenib—thyroid cancer	0.00225	0.00455	CcSEcCtD
Argatroban—Renal impairment—Epirubicin—thyroid cancer	0.00225	0.00455	CcSEcCtD
Argatroban—Dermatitis bullous—Epirubicin—thyroid cancer	0.00224	0.00453	CcSEcCtD
Argatroban—Cardiac failure—Epirubicin—thyroid cancer	0.00219	0.00444	CcSEcCtD
Argatroban—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00218	0.00442	CcSEcCtD
Argatroban—Renal failure acute—Doxorubicin—thyroid cancer	0.00214	0.00434	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00214	0.00433	CcSEcCtD
Argatroban—Hypersensitivity—Sorafenib—thyroid cancer	0.0021	0.00424	CcSEcCtD
Argatroban—Renal impairment—Doxorubicin—thyroid cancer	0.00208	0.00421	CcSEcCtD
Argatroban—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00207	0.00419	CcSEcCtD
Argatroban—Cardiac arrest—Epirubicin—thyroid cancer	0.00203	0.00412	CcSEcCtD
Argatroban—Cardiac failure—Doxorubicin—thyroid cancer	0.00203	0.00411	CcSEcCtD
Argatroban—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00202	0.00409	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.00198	0.00401	CcSEcCtD
Argatroban—Diarrhoea—Sorafenib—thyroid cancer	0.00195	0.00394	CcSEcCtD
Argatroban—Cardiac arrest—Doxorubicin—thyroid cancer	0.00188	0.00381	CcSEcCtD
Argatroban—Dizziness—Sorafenib—thyroid cancer	0.00188	0.00381	CcSEcCtD
Argatroban—Vomiting—Sorafenib—thyroid cancer	0.00181	0.00366	CcSEcCtD
Argatroban—Angina pectoris—Epirubicin—thyroid cancer	0.0018	0.00365	CcSEcCtD
Argatroban—Rash—Sorafenib—thyroid cancer	0.00179	0.00363	CcSEcCtD
Argatroban—Dermatitis—Sorafenib—thyroid cancer	0.00179	0.00363	CcSEcCtD
Argatroban—Headache—Sorafenib—thyroid cancer	0.00178	0.00361	CcSEcCtD
Argatroban—Nausea—Sorafenib—thyroid cancer	0.00169	0.00342	CcSEcCtD
Argatroban—Angina pectoris—Doxorubicin—thyroid cancer	0.00167	0.00337	CcSEcCtD
Argatroban—Pneumonia—Epirubicin—thyroid cancer	0.00166	0.00336	CcSEcCtD
Argatroban—Urinary tract infection—Epirubicin—thyroid cancer	0.0016	0.00324	CcSEcCtD
Argatroban—Haematuria—Epirubicin—thyroid cancer	0.00157	0.00318	CcSEcCtD
Argatroban—Pneumonia—Doxorubicin—thyroid cancer	0.00153	0.00311	CcSEcCtD
Argatroban—Bradycardia—Epirubicin—thyroid cancer	0.00151	0.00305	CcSEcCtD
Argatroban—Haemoglobin—Epirubicin—thyroid cancer	0.00149	0.00301	CcSEcCtD
Argatroban—Urinary tract infection—Doxorubicin—thyroid cancer	0.00148	0.003	CcSEcCtD
Argatroban—Haemorrhage—Epirubicin—thyroid cancer	0.00148	0.003	CcSEcCtD
Argatroban—Haematuria—Doxorubicin—thyroid cancer	0.00145	0.00294	CcSEcCtD
Argatroban—Bradycardia—Doxorubicin—thyroid cancer	0.00139	0.00282	CcSEcCtD
Argatroban—Haemoglobin—Doxorubicin—thyroid cancer	0.00138	0.00279	CcSEcCtD
Argatroban—Haemorrhage—Doxorubicin—thyroid cancer	0.00137	0.00277	CcSEcCtD
Argatroban—Angiopathy—Epirubicin—thyroid cancer	0.00134	0.00272	CcSEcCtD
Argatroban—Back pain—Epirubicin—thyroid cancer	0.00125	0.00252	CcSEcCtD
Argatroban—Angiopathy—Doxorubicin—thyroid cancer	0.00124	0.00251	CcSEcCtD
Argatroban—Back pain—Doxorubicin—thyroid cancer	0.00115	0.00233	CcSEcCtD
Argatroban—Cough—Epirubicin—thyroid cancer	0.00112	0.00228	CcSEcCtD
Argatroban—Chest pain—Epirubicin—thyroid cancer	0.0011	0.00222	CcSEcCtD
Argatroban—Confusional state—Epirubicin—thyroid cancer	0.00106	0.00215	CcSEcCtD
Argatroban—Infection—Epirubicin—thyroid cancer	0.00104	0.00211	CcSEcCtD
Argatroban—Cough—Doxorubicin—thyroid cancer	0.00104	0.00211	CcSEcCtD
Argatroban—Tachycardia—Epirubicin—thyroid cancer	0.00103	0.00208	CcSEcCtD
Argatroban—Chest pain—Doxorubicin—thyroid cancer	0.00102	0.00205	CcSEcCtD
Argatroban—Hypotension—Epirubicin—thyroid cancer	0.000983	0.00199	CcSEcCtD
Argatroban—Confusional state—Doxorubicin—thyroid cancer	0.000981	0.00199	CcSEcCtD
Argatroban—Infection—Doxorubicin—thyroid cancer	0.000967	0.00196	CcSEcCtD
Argatroban—Tachycardia—Doxorubicin—thyroid cancer	0.00095	0.00192	CcSEcCtD
Argatroban—Dyspnoea—Epirubicin—thyroid cancer	0.000938	0.0019	CcSEcCtD
Argatroban—Dyspepsia—Epirubicin—thyroid cancer	0.000926	0.00187	CcSEcCtD
Argatroban—Hypotension—Doxorubicin—thyroid cancer	0.000909	0.00184	CcSEcCtD
Argatroban—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000908	0.00184	CcSEcCtD
Argatroban—Constipation—Epirubicin—thyroid cancer	0.000899	0.00182	CcSEcCtD
Argatroban—Pain—Epirubicin—thyroid cancer	0.000899	0.00182	CcSEcCtD
Argatroban—Dyspnoea—Doxorubicin—thyroid cancer	0.000868	0.00176	CcSEcCtD
Argatroban—Feeling abnormal—Epirubicin—thyroid cancer	0.000867	0.00175	CcSEcCtD
Argatroban—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00086	0.00174	CcSEcCtD
Argatroban—Dyspepsia—Doxorubicin—thyroid cancer	0.000857	0.00173	CcSEcCtD
Argatroban—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00084	0.0017	CcSEcCtD
Argatroban—Constipation—Doxorubicin—thyroid cancer	0.000832	0.00168	CcSEcCtD
Argatroban—Pain—Doxorubicin—thyroid cancer	0.000832	0.00168	CcSEcCtD
Argatroban—Body temperature increased—Epirubicin—thyroid cancer	0.000832	0.00168	CcSEcCtD
Argatroban—Abdominal pain—Epirubicin—thyroid cancer	0.000832	0.00168	CcSEcCtD
Argatroban—Feeling abnormal—Doxorubicin—thyroid cancer	0.000802	0.00162	CcSEcCtD
Argatroban—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000796	0.00161	CcSEcCtD
Argatroban—Hypersensitivity—Epirubicin—thyroid cancer	0.000775	0.00157	CcSEcCtD
Argatroban—Abdominal pain—Doxorubicin—thyroid cancer	0.000769	0.00156	CcSEcCtD
Argatroban—Body temperature increased—Doxorubicin—thyroid cancer	0.000769	0.00156	CcSEcCtD
Argatroban—Diarrhoea—Epirubicin—thyroid cancer	0.00072	0.00146	CcSEcCtD
Argatroban—Hypersensitivity—Doxorubicin—thyroid cancer	0.000717	0.00145	CcSEcCtD
Argatroban—Dizziness—Epirubicin—thyroid cancer	0.000696	0.00141	CcSEcCtD
Argatroban—Vomiting—Epirubicin—thyroid cancer	0.000669	0.00135	CcSEcCtD
Argatroban—Diarrhoea—Doxorubicin—thyroid cancer	0.000666	0.00135	CcSEcCtD
Argatroban—Rash—Epirubicin—thyroid cancer	0.000663	0.00134	CcSEcCtD
Argatroban—Dermatitis—Epirubicin—thyroid cancer	0.000663	0.00134	CcSEcCtD
Argatroban—Headache—Epirubicin—thyroid cancer	0.000659	0.00133	CcSEcCtD
Argatroban—Dizziness—Doxorubicin—thyroid cancer	0.000644	0.0013	CcSEcCtD
Argatroban—Nausea—Epirubicin—thyroid cancer	0.000625	0.00126	CcSEcCtD
Argatroban—Vomiting—Doxorubicin—thyroid cancer	0.000619	0.00125	CcSEcCtD
Argatroban—Rash—Doxorubicin—thyroid cancer	0.000614	0.00124	CcSEcCtD
Argatroban—Dermatitis—Doxorubicin—thyroid cancer	0.000613	0.00124	CcSEcCtD
Argatroban—Headache—Doxorubicin—thyroid cancer	0.00061	0.00123	CcSEcCtD
Argatroban—Nausea—Doxorubicin—thyroid cancer	0.000578	0.00117	CcSEcCtD
